Assessment of the Benefit of Teleconsultations for Children With Autism Spectrum Disorders

December 15, 2016 updated by: Assistance Publique - Hôpitaux de Paris
The purpose of this study is to determine whether Teleconsultation would a)be effective and cost-effective by increasing the proportion of patients with Autism Spectrum Disorders having a correct follow-up, and less transportation, and b) get a high satisfaction from the parents and from the professionals

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Carrieres sur Poissy, France, 78955
        • Recruiting
        • IME notre Ecole
        • Contact:
          • Amélie Couteau
      • Chambourcy, France, 78240
        • Recruiting
        • Association Agir et Vivre l'Autisme
        • Contact:
          • Stéphane Da
      • Collegien, France, 77090
        • Recruiting
        • IME Eclair
        • Contact:
          • Liora CRESPIN
      • Dammarie les Lys, France, 77190
        • Recruiting
        • Association UNI-TEDS
        • Contact:
          • Slimane Haddadi
      • Paris, France, 75014
      • Vert saint denis, France, 77240
        • Recruiting
        • IME Le Reverdi
        • Contact:
          • Christine CARNIAC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Residents of medico-social structure accepting children and adolescent with autism disorders

Description

Inclusion Criteria:

  • All residents of medico-social structures accepting children and adolescent with autism disorders

Exclusion Criteria:

  • Refusal of parents that their child use telemedicine
  • Refusal of parents that their child participate to the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Group with teleconsultation - before period
Group without teleconsultation - before period
Group with teleconsultation - after period
Group without teleconsultation - after period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite score: CARS, VABS evaluated once a year and ADI-R at least once in the lifetime
Time Frame: One year after the start of the "before" period and one year after the start of the "after" period
Score equals 1 if all three evaluations are performed, 0 otherwise
One year after the start of the "before" period and one year after the start of the "after" period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Catherine Doyen, MD, Hopital Sainte Anne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

December 15, 2016

First Submitted That Met QC Criteria

December 15, 2016

First Posted (Estimate)

December 19, 2016

Study Record Updates

Last Update Posted (Estimate)

December 19, 2016

Last Update Submitted That Met QC Criteria

December 15, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TLM Prometted

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe